10x Genomics
TXG
$27.51
Share price
2.27%
Change (1 day)
-46.02%
Change (1 year)
Categories
10x Genomics (TXG) - P/B ratio
P/B ratio as of April 2024 : 4.42
According to 10x Genomics
's latest financial reports the company has a price-to-book ratio of 4.42.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
10x Genomics - P/B ratio (from 2019 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 8.93 | 72.44% |
| 2022-12-31 | 5.18 | -74.57% |
| 2021-12-31 | 20.4 | -1.28% |
| 2020-12-31 | 20.6 | 18.02% |
| 2019-12-31 | 17.5 | |
| 2018-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 Organovo ONVO | 1.62 | -63.33% | 🇺🇸 USA |
 Orchard Therapeutics
ORTX | 4.74 | 7.06% | 🇬🇧 UK |
 Novavax NVAX | -0.7890 | -117.84% | 🇺🇸 USA |
 Novocure
NVCR | 3.70 | -16.32% | Jersey |